Exploring serum &alpha;‑synuclein and its autoantibodies in essential tremor: implications for diagnosis and symptom correlations

Shalash,Ali; Doma,Ahmed; Barakat,Mai; Hamid,Eman; Salama,Mohamed

doi:10.3892/br.2024.1796

Exploring serum α‑synuclein and its autoantibodies in essential tremor: implications for diagnosis and symptom correlations

Authors:
- Ali Shalash
- Ahmed Doma
- Mai Barakat
- Eman Hamid
- Mohamed Salama
View Affiliations

Affiliations: Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo 11757, Egypt, Institute of Global Health and Human Ecology, The American University in Cairo, Cairo 11385, Egypt
Published online on: June 4, 2024 https://doi.org/10.3892/br.2024.1796
Article Number: 108
Copyright: © Shalash et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There is no definite biomarker for confirming the diagnosis of essential tremor (ET) or differentiating it from other diseases, particularly Parkinson's disease. The present study aimed to investigate the serum levels of the α‑synuclein protein (α‑syn) and its autoantibodies in patients with ET compared with healthy controls and its relation to motor and non‑motor symptoms in patients with ET. Serum α‑syn and its autoantibodies were measured in 32 patients with ET and 32 age‑ and sex‑matched controls. Both groups were assessed using the non‑motor symptoms scale, MoCA, Beck Depression Inventory, Hamilton Anxiety Rating Scale, and the Short Form 36 Health Survey Questionnaire. Tremor was assessed using the Fahn‑Tolosa‑Marin Tremor Rating Scale. The serum α‑syn concentration in patients with ET was significantly lower than that in healthy controls (P<0.001), with a positive predictive value of 0.81 and a negative predictive value of 0.75, while the serum anti‑a‑syn autoantibody concentration was not significantly different between the two groups. There were no correlations between serum α‑syn or its autoantibodies and patients' clinical characteristics. Furthermore, patients with ET had worse cognitive impairment, depression, anxiety, non‑motor symptoms and quality of life. The serum α‑syn concentration was lower in patients with ET than in controls, with favorable predictive values, suggesting that it could serve as a biomarker for ET diagnosis.

View Figures

View References

1	Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM and Deuschl G: Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 33:75–87. 2018.PubMed/NCBI View Article : Google Scholar
2	Lee SM, Kim M, Lee HM, Kwon KY and Koh SB: Nonmotor symptoms in essential tremor: Comparison with Parkinson's disease and normal control. J Neurol Sci. 349:168–173. 2015.PubMed/NCBI View Article : Google Scholar
3	Shalash AS, Hamid E, Elrassas H, Bahbah EI, Mansour AH, Mohamed H and Elbalkimy M: Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease. PLoS One. 16(e0245918)2021.PubMed/NCBI View Article : Google Scholar
4	Shalash AS, Mohamed H, Mansour AH, Elkady A, Elrassas H, Hamid E and Elbalkimy MH: Clinical profile of non-motor symptoms in patients with essential tremor: Impact on quality of life and age-related differences. Tremor Other Hyperkinet Mov (N Y). 9(10.7916/tohm.v0.736)2019.PubMed/NCBI View Article : Google Scholar
5	Espay AJ, Lang AE, Erro R, Merola A, Fasano A, Berardelli A and Bhatia KP: Essential pitfalls in ‘essential’ tremor. Mov Disord. 32:325–331. 2017.PubMed/NCBI View Article : Google Scholar
6	Atik A, Stewart T and Zhang J: Alpha-Synuclein as a Biomarker for Parkinson's Disease. Brain Pathol. 26:410–418. 2016.PubMed/NCBI View Article : Google Scholar
7	Altay MF, Liu AKL, Holton JL, Parkkinen L and Lashuel HA: Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta Neuropathol Commun. 10(163)2022.PubMed/NCBI View Article : Google Scholar
8	Louis ED, Iglesias-Hernandez D, Hernandez NC, Flowers X, Kuo SH, Vonsattel JPG and Faust PL: Characterizing lewy pathology in 231 essential tremor brains from the essential tremor centralized brain repository. J Neuropathol Exp Neurol. 81:796–806. 2022.PubMed/NCBI View Article : Google Scholar
9	Ganguly U, Singh S, Pal S, Prasad S, Agrawal BK, Saini RV and Chakrabarti S: Alpha-synuclein as a biomarker of Parkinson's disease: Good, but not good enough. Front Aging Neurosci. 13(702639)2021.PubMed/NCBI View Article : Google Scholar
10	Shalash A, Salama M, Makar M, Roushdy T, Elrassas HH, Mohamed W, El-Balkimy M and Abou Donia M: Elevated Serum α-Synuclein autoantibodies in patients with Parkinson's disease relative to Alzheimer's disease and controls. Front Neurol. 8(720)2017.PubMed/NCBI View Article : Google Scholar
11	Thenganatt MA and Jankovic J: The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 22 (Suppl 1):S162–S165. 2016.PubMed/NCBI View Article : Google Scholar
12	Albillos SM, Montero O, Calvo S, Solano B, Trejo JM and Cubo E: Can Plasma α-synuclein help us to differentiate Parkinson's disease from essential tremor? Tremor Other Hyperkinet Mov (NY). 11(20)2021.PubMed/NCBI View Article : Google Scholar
13	Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, et al: The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord. 22:1901–1911. 2007.PubMed/NCBI View Article : Google Scholar
14	Abdel Rahman TT and El Gaafary MM: Montreal cognitive assessment arabic version: Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int. 9:54–61. 2009.PubMed/NCBI View Article : Google Scholar
15	Beck AT, Ward CH, Mendelson M, Mock J and Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 4:561–571. 1961.PubMed/NCBI View Article : Google Scholar
16	Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol. 32:50–55. 1959.PubMed/NCBI View Article : Google Scholar
17	Coons SJ, Alabdulmohsin SA, Draugalis JR and Hays RD: Reliability of an Arabic version of the RAND-36 Health Survey and its equivalence to the US-English version. Med Care. 36:428–432. 1998.PubMed/NCBI View Article : Google Scholar
18	Yu Z, Liu G, Zheng Y, Huang G and Feng T: Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson's disease. Front Neurol. 14(1173074)2023.PubMed/NCBI View Article : Google Scholar
19	Yoo SW, Ha S, Lyoo CH, Kim Y, Yoo JY and Kim JS: Exploring the link between essential tremor and Parkinson's disease. NPJ Parkinsons Dis. 9(134)2023.PubMed/NCBI View Article : Google Scholar
20	Garg P, Maass F, Sundaram SM, Mollenhauer B, Mahajani S, van Riesen C, Kugler S and Bahr M: The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease. Mol Cell Neurosci. 121(103746)2022.PubMed/NCBI View Article : Google Scholar
21	Sengul Y, Sengul HS, Yucekaya SK, Yucel S, Bakim B, Pazarci NK and Ozdemir G: Cognitive functions, fatigue, depression, anxiety, and sleep disturbances: Assessment of nonmotor features in young patients with essential tremor. Acta Neurol Belg. 115:281–287. 2015.PubMed/NCBI View Article : Google Scholar
22	Chandran V and Pal PK: Essential tremor: Beyond the motor features. Parkinsonism Relat Disord. 18:407–413. 2012.PubMed/NCBI View Article : Google Scholar
23	Huey ED, Cosentino S, Chapman S, Azar M, Rohl B, Collins K, Morgan S, Liu X and Louis ED: Self-report depressive symptoms are dissociated from tremor severity in essential tremor. Parkinsonism Relat Disord. 50:87–93. 2018.PubMed/NCBI View Article : Google Scholar
24	Musacchio T, Purrer V, Papagianni A, Fleischer A, Mackenrodt D, Malsch C, Gelbrich G, Steigerwald F, Volkmann J and Klebe S: Non-Motor symptoms of essential tremor are independent of tremor severity and have an impact on quality of life. Tremor Other Hyperkinet Mov (N Y). 6(361)2016.PubMed/NCBI View Article : Google Scholar
25	Lombardi WJ, Woolston DJ, Roberts JW and Gross RE: Cognitive deficits in patients with essential tremor. Neurology. 57:785–790. 2001.PubMed/NCBI View Article : Google Scholar
26	Dogu O, Louis ED, Sevim S, Kaleagasi H and Aral M: Clinical characteristics of essential tremor in Mersin, Turkey-a population-based door-to-door study. J Neurol. 252:570–574. 2005.PubMed/NCBI View Article : Google Scholar
27	Louis ED: Non-motor symptoms in essential tremor: A review of the current data and state of the field. Parkinsonism Relat Disord. 22 (Suppl 1):S115–S118. 2016.PubMed/NCBI View Article : Google Scholar